Matching slides 40,452
Current window 21,751-21,780
Pages 1,349
Rows per page 30

Beat

21,751-21,780 of 40,452

filter-aware
12
The slide uses a highlighted column for Allego to emphasize its competitive positioning.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
13
Allego | Investor Presentation Deck | 50 slidesAllego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
14
The slide uses a graphical arrow overlay to direct attention to the right, consistent with the brand's visual identity.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
29
The central graphic is a circular puzzle diagram representing the three key stakeholders.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
30
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
31
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
32
The slide uses a timeline-style process flow to show data integration.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
33
Includes a disclaimer about compliance and separation of ads from clinical workflows.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
34
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
35
Uses a Situation-Approach-Outcomes framework.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
36
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
37
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
38
The slide shows two line charts side-by-side tracking margin improvements.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
39
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
40
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
09
The slide uses a checkmark-based list format to emphasize defensive moats.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Beat · Market Size1 hit
12
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Beat · Competition1 hit
06
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Team1 hit
20
The slide uses a combination of a timeline/map graphic and a bar chart to demonstrate market penetration and adoption speed.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
21
Comparison of molecular weight (25 kDa vs 150 kDa) and administration method.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
22
Includes clinical trial design diagram for Part A and Part B.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
23
Includes a biological pathway diagram and a comparison of circulating concentrations.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
24
The slide uses a horizontal timeline-like structure to compare three drug candidates (ALXN2040, ALXN2050, ALXN2080).AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
25
Includes FDA Breakthrough Designation callout and trial design diagrams.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
26
The slide uses a human-centric approach to introduce a strategic section.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
27
The slide uses a pyramid to segment the market by patient need and product modality.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
28
Uses a pictograph to represent patient population segments.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
29
The chart shows a comparison of branded vs unbranded/off-label market size over time, and a pie chart showing patient source.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
04
The slide uses a combination of headshots for the team and a metric-based footer to establish credibility.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · Team1 hit
27
The slide uses a split-layout: left side defines the problem and market size, right side details the unaddressed need.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · Market Size1 hit